Revision as of 20:30, 2 December 2023

This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page.

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Bone Health

2009: Gralow et al. NCCN Task Force Report: Bone Health in Cancer Care. PubMed

Cancer Screening

2018: Bevers et al. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. PubMed
2003: Authors not listed. Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology. PubMed

Cancer Related Infections

2016: Baden et al. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. PubMed
2012: Baden et al. Prevention and treatment of cancer-related infections. PubMed
2008: Segal et al. Prevention and treatment of cancer-related infections. PubMed

Cancer Risk Reduction

2015: Bevers et al. Breast Cancer Risk Reduction, Version 2.2015. PubMed
2003: Authors not listed. Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology. PubMed

Middle East and North Africa

2010: Abulkhair et al. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. PubMed
2010: Içli et al. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. PubMed
2010: Yusuf et al. Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region. PubMed
2010: Bazarbachi et al. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. PubMed
2010: Jazieh et al. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region. PubMed
2010: Shamieh et al. Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region. PubMed
2010: Hassen et al. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region. PubMed

Myeloid Growth Factor

2013: Crawford et al. Myeloid growth factors. PubMed
2011: Crawford et al. Myeloid growth factors. PubMed
2009: Crawford et al. Myeloid growth factors. PubMed
2007: Crawford et al. Myeloid growth factors. Clinical practice guidelines in oncology. PubMed
2005: Crawford et al. Myeloid growth factors clinical practice guidelines in oncology. PubMed

Survivorship

2017: Denlinger et al. Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. PubMed
2014: Denlinger et al. Survivorship: healthy lifestyles, version 2.2014. PubMed
2014: Denlinger et al. Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology. PubMed
2014: Denlinger et al. Survivorship: pain version 1.2014. PubMed
2014: Denlinger et al. Survivorship: sexual dysfunction (female), version 1.2013. PubMed
2014: Denlinger et al. Survivorship: sexual dysfunction (male), version 1.2013. PubMed
2014: Denlinger et al. Survivorship: sleep disorders, version 1.2014. PubMed

Fatigue

2010: Berger et al. NCCN Clinical Practice Guidelines Cancer-related fatigue. PubMed

@@ Line 2: / Line 2: @@
 '''Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.'''
+=Bone Health=
+*'''2009:''' Gralow et al. [https://doi.org/10.6004/Jnccn.2009.0076 NCCN Task Force Report: Bone Health in Cancer Care.] [https://pubmed.ncbi.nlm.nih.gov/19555589/ PubMed]
 =Cancer Screening=

Difference between revisions of "NCCN guidelines"